TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Natural Capsules Limited ( (IN:NATCAPSUQ) ) has shared an announcement.
Natural Capsules Limited reported its financial results for Q1FY26, highlighting a revenue of ₹45.20 Cr and an EBITDA of ₹0.32 Cr with margins at 0.71%. Despite a stable quarter for its capsules business, the company plans to capitalize on rising demand for HPMC capsules due to US duties on Chinese imports by expanding production lines. The API segment shows signs of improvement, with increased realisations for steroidal APIs, and the company aims to achieve cash breakeven at its API facility by the end of Q2. These strategic moves are expected to drive growth and improve profitability.
More about Natural Capsules Limited
Natural Capsules Limited is a leading Indian manufacturer of hard capsule shells, known for pioneering vegetarian capsules in India. It is the second largest manufacturer of gelatin capsules in the country and has expanded its operations to include API manufacturing through its subsidiary, Natural Biogenex Private Limited.
Average Trading Volume: 2,178
Technical Sentiment Signal: Sell
Current Market Cap: 2.21B INR
Learn more about NATCAPSUQ stock on TipRanks’ Stock Analysis page.